Exosens Shares Dip Below €60 but Still Up +66% Over the Year
Exosens shares fell by 2.69% to €59.75 in mid-afternoon trading this Friday, in a downward-trending Paris market. The SBF 120, the benchmark index for the stock, is down 0.68% at 6,186.85 points. The decline is part of a challenging week for the night vision and imaging technology specialist for defense, which has lost nearly 8% over seven days.
With a session decline of 2.69%, Exosens is among the five largest drops in the SBF 120, close to Exail Technologies, Thales, and Air France-KLM. The stock has fallen below the €60 threshold to €59.75, down from €61.40 at the previous day's close. Despite this decline, the annual performance remains strong, at +66.67% over twelve months, and nearly 14.5% over three months. The stock is part of an overall defensive session: the CAC 40 is down 0.73% at 8,142.46 points, and the DAX has fallen by 0.66%. A previous brief on the stock, dated May 7, already mentioned a mid-session price of €63.40, continuing the short-term downward trend.
Tense Technical Setup, Next Meeting on May 22
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The stock price is now below the lower Bollinger Band, set at €61.32, signaling an oversold condition following the week's slide. The RSI at 43 remains neutral and does not yet indicate seller exhaustion. The stock is also approaching its support level at €57.50. On the corporate front, the company released a technical document on May 7 detailing the applications of its SWIR cameras for industrial and food sorting, expanding its applications beyond defense. As a reminder, the first quarter revenue, published on April 29, was €122.6 million, up 19.7%. The next scheduled financial event is the general assembly 2026, set for May 22.
Porté par une dynamique commerciale soutenue, en particulier sur les marchés de la Défense et de la Surveillance, ainsi que par une solide exécution opérationnelle
Risks mentioned
Charge de dépréciation de la marque de 28,2 M€ pesant sur le résultat net publié, en baisse de 45,0 %
Incertitudes persistantes sur la recherche scientifique pesant sur la demande en Sciences de la Vie
Contraction de 60 points de base de la marge brute du segment Détection & Imagerie (mix produits)
Opportunities identified
Attribution par l'US Army du contrat IDIQ BiNOD ouvrant le marché américain de la défense
Plan d'expansion de +40 % des capacités de production d'ici 2027, premiers bénéfices au S2 2026
Acquisition d'Emberion, capteurs infrarouges SWIR à points quantiques
Outlook / guidance
Expected revenue: 530 millions d'euros
Expected EBITDA: 173 millions d'euros
Management commentary: chiffre d'affaires compris entre 520 millions d'euros et 540 millions d'euros ; • EBITDA ajusté compris entre 168 millions d'euros et 178 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
